NEW YORK--(BUSINESS WIRE)--Broadwood Partners, L.P. and its affiliates (“Broadwood” or “we”) today announced that Glass, Lewis & Co., LLC (“Glass Lewis”), a leading independent proxy advisory firm, ...

We came across a bullish thesis on STAAR Surgical Company on Yet Another Value Blog’s Substack. In this article, we will summarize the bulls’ thesis on STAA. STAAR Surgical Company’s share was trading ...

Staar Surgical receives key FDA approval that will expand the market size for its key product Staar Surgical Co. today announced that its board of directors has appointed Chief Operating Officer and ...

Neal Bradsher and Richard LeBuhn of Broadwood Partners, along with Christopher Wang of Yunqi Capital, have joined STAAR's Board of Directors following a cooperation agreement. This change also sees ...

Staar Surgical will remain independent after a bitter shareholder battle that has raged for the past several months has now ended the attempted buyout of the company by Alcon. Alcon announced its ...

Please provide your email address to receive an email when new articles are posted on . STAAR Surgical did not receive the necessary stockholder votes to move forward with the merger. STAAR will ...

Jan 6 (Reuters) - STAAR Surgical (STAA.O), opens new tab said on Tuesday it plans to terminate its merger agreement with Swiss eyecare giant Alcon (ALCC.S), opens new tab after failing to secure ...

STAAR Surgical Company (NASDAQ: STAA) announced Tuesday that it did not receive the necessary stockholder votes to approve the merger agreement with Alcon Inc. (NYSE: ALC) at the Special Meeting of ...

Shareholders of Staar Surgical rejected a proposal to sell the company to Alcon for about $1.6 billion, a win for activist investors who had campaigned to block the deal Staar, a maker of implantable ...

Staar Surgical Co. said it plans to terminate its proposed $1.6 billion sale to Alcon Inc. based on preliminary results from today’s shareholder vote. As a result, Staar will remain a standalone, ...

An update from Staar Surgical ( (STAA)) is now available. On January 6, 2026, STAAR Surgical reported that preliminary voting results from a special meeting of stockholders showed the company did not ...

Dallas-based Slotnik Capital acquired 635,000 shares of STAAR Surgical, adding an estimated $17.06 million position. The transaction resulted in a position representing 5.33% of Slotnik Capital's 13F ...